µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© 2Q]W
`MCtm(<
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© xg^%8Ls^
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© r#1W$~?>
1.Co-stimulators (or co-stimulating molecules) .>[l@x"
2.NK-kB oq,nfU
A
3.Immunoglobulin superfamily i<>%y*+@
4.antigen-presenting cell (APC) x\~ <8o
5.death domain .=<s@Sg,t
6.CCR and CXCR }Rh%bf7,
7.Lectin (or mitogen) &s}sA+w
8.Clusters of differentiation, CD) i%<NKE;v7m
9.B7 family O`%F{&;29
10.Cytotoxic T lymphocyte, CTL) <8?
F\x@
11.IL-15 and IL-15 receptor (IL-15R) Qnt}:M+
12.MHC restriction o@dTiQK_
13.Affinity-chromatography LH+Bu%s
14.Cyctosprin A, CsA SB('Nqih
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) >Z3>
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 3WwCo.q;m
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 LY)Wwl*wc
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ Wtk|}>Pf
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ ;vPFRiFK
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© No[9m_
ÃâÒßѧרҵ£º c V@^<
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ hS &H*
Ïû»¯ÄÚ¿Æ£º jr.{M
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ Eul3 {+]
ѪҺ²¡Ñ§×¨Òµ£º kCz2uG)l
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿